Clinical Trials
2 trialsNCT05054478 2021-09-23
PCL-2
Assistance Publique - Hôpitaux de Paris
Phase 2 Not yet recruiting
NCT03591744 2018-12-19
Daratumumab, Bortezomib, Dexamethasone, Pegylated Liposomal Doxorubicin Hydrochloride, and Lenalidomide in Treating Participants With Plasma Cell Leukemia
City of Hope Medical Center
Phase 1 Withdrawn